Clinical Trial Update: Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)

View source ↗

Summary

A completed observational trial assessing relapse rates in Hepatitis C patients treated with peginterferon alfa-2b plus ribavirin in routine clinical practice i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Peginterferon alfa-2b (Peginterferon alfa-2b)
• Ribavirin (ribavirin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Hepatitis C, Hepatitis C, Chronic | Status: TERMINATED | Results posted: 2012-08-07